MTOR and pulmonary arterial hypertension: The disruption of mTORC1 in SMCs ameliorates the development of experimental PAH; however, disruption of mTORC2 leads to spontaneous PAH [58], which indicates that the mTOR signaling pathway is a critical modulator in PAH development.